<VariationArchive VariationID="424725" VariationName="NM_003560.3(PLA2G6):c.[1351delC];[1942G&gt;A]" VariationType="CompoundHeterozygote" Accession="VCV000424725" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2015-07-03" MostRecentSubmission="2015-07-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Genotype VariationID="424725">
      <SimpleAllele AlleleID="169797" VariationID="159730">
        <GeneList>
          <Gene Symbol="PLA2G6" FullName="phospholipase A2 group VI" GeneID="8398" HGNC_ID="HGNC:9039" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>22q13.1</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="38111495" stop="38181830" display_start="38111495" display_stop="38181830" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="38507501" stop="38577835" display_start="38507501" display_stop="38577835" Strand="-" />
            </Location>
            <OMIM>603604</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_003560.4(PLA2G6):c.1351del (p.Leu451fs)</Name>
        <CanonicalSPDI>NC_000022.11:38126446:G:</CanonicalSPDI>
        <VariantType>Deletion</VariantType>
        <Location>
          <CytogeneticLocation>22q13.1</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="38126447" stop="38126447" display_start="38126447" display_stop="38126447" variantLength="1" positionVCF="38126446" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="38522454" stop="38522454" display_start="38522454" display_stop="38522454" variantLength="1" positionVCF="38522453" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        </Location>
        <ProteinChange>L273fs</ProteinChange>
        <ProteinChange>L219fs</ProteinChange>
        <ProteinChange>L225fs</ProteinChange>
        <ProteinChange>L397fs</ProteinChange>
        <ProteinChange>L451fs</ProteinChange>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.38522454del" Assembly="GRCh37">
              <Expression>NC_000022.10:g.38522454del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.38126447del" Assembly="GRCh38">
              <Expression>NC_000022.11:g.38126447del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_007094.3" sequenceAccession="NG_007094" sequenceVersion="3" change="g.93332del">
              <Expression>NG_007094.3:g.93332del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001004426.3" sequenceAccession="NM_001004426" sequenceVersion="3" change="c.1189del">
              <Expression>NM_001004426.3:c.1189del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001004426.1" sequenceAccession="NP_001004426" sequenceVersion="1" change="p.Leu397fs">
              <Expression>NP_001004426.1:p.Leu397fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001199562.3" sequenceAccession="NM_001199562" sequenceVersion="3" change="c.1189del">
              <Expression>NM_001199562.3:c.1189del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001186491.1" sequenceAccession="NP_001186491" sequenceVersion="1" change="p.Leu397fs">
              <Expression>NP_001186491.1:p.Leu397fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001349864.2" sequenceAccession="NM_001349864" sequenceVersion="2" change="c.1351del">
              <Expression>NM_001349864.2:c.1351del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001336793.1" sequenceAccession="NP_001336793" sequenceVersion="1" change="p.Leu451fs">
              <Expression>NP_001336793.1:p.Leu451fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001349865.2" sequenceAccession="NM_001349865" sequenceVersion="2" change="c.1189del">
              <Expression>NM_001349865.2:c.1189del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001336794.1" sequenceAccession="NP_001336794" sequenceVersion="1" change="p.Leu397fs">
              <Expression>NP_001336794.1:p.Leu397fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001349866.2" sequenceAccession="NM_001349866" sequenceVersion="2" change="c.1189del">
              <Expression>NM_001349866.2:c.1189del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001336795.1" sequenceAccession="NP_001336795" sequenceVersion="1" change="p.Leu397fs">
              <Expression>NP_001336795.1:p.Leu397fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001349867.2" sequenceAccession="NM_001349867" sequenceVersion="2" change="c.817del">
              <Expression>NM_001349867.2:c.817del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001336796.1" sequenceAccession="NP_001336796" sequenceVersion="1" change="p.Leu273fs">
              <Expression>NP_001336796.1:p.Leu273fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001349868.2" sequenceAccession="NM_001349868" sequenceVersion="2" change="c.673del">
              <Expression>NM_001349868.2:c.673del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001336797.1" sequenceAccession="NP_001336797" sequenceVersion="1" change="p.Leu225fs">
              <Expression>NP_001336797.1:p.Leu225fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001349869.2" sequenceAccession="NM_001349869" sequenceVersion="2" change="c.655del">
              <Expression>NM_001349869.2:c.655del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001336798.1" sequenceAccession="NP_001336798" sequenceVersion="1" change="p.Leu219fs">
              <Expression>NP_001336798.1:p.Leu219fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_003560.4" sequenceAccession="NM_003560" sequenceVersion="4" change="c.1351del" MANESelect="true">
              <Expression>NM_003560.4:c.1351del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_003551.2" sequenceAccession="NP_003551" sequenceVersion="2" change="p.Leu451fs">
              <Expression>NP_003551.2:p.Leu451fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_1015" sequenceAccession="LRG_1015">
              <Expression>LRG_1015:g.93332del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_1015t1" sequenceAccession="LRG_1015t1">
              <Expression>LRG_1015t1:c.1351del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_1015p1" sequenceAccession="LRG_1015p1" change="p.Leu451fs">
              <Expression>LRG_1015p1:p.Leu451fs</Expression>
            </ProteinExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2023-12-27" DateCreated="2014-11-21" MostRecentSubmission="2024-06-20" NumberOfSubmissions="5" NumberOfSubmitters="5">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">16783378</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">18570303</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">18799783</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">22213678</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">24628589</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">28714225</ID>
            </Citation>
            <ConditionList>
              <TraitSet ID="33682" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="18389" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">phospholipase A2-associated neurodegeneration</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">PLA2G6-associated neurodegeneration</ElementValue>
                    <XRef ID="MONDO:0017998" DB="MONDO" />
                    <XRef ID="329303" DB="Orphanet" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">PLAN</ElementValue>
                    <XRef Type="MIM" ID="256600" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="12567" />
                    <XRef ID="12567" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">PLA2G6-associated neurodegeneration (PLAN) comprises a continuum of three phenotypes with overlapping clinical and radiologic features: Infantile neuroaxonal dystrophy (INAD). Atypical neuroaxonal dystrophy (atypical NAD). PLA2G6-related dystonia-parkinsonism. INAD usually begins between ages six months and three years with psychomotor regression or delay, hypotonia, and progressive spastic tetraparesis. Many affected children never learn to walk or lose the ability shortly after attaining it. Strabismus, nystagmus, and optic atrophy are common. Disease progression is rapid, resulting in severe spasticity, progressive cognitive decline, and visual impairment. Many affected children do not survive beyond their first decade. Atypical NAD shows more phenotypic variability than INAD. In general, onset is in early childhood but can be as late as the end of the second decade. The presenting signs may be gait instability, ataxia, or speech delay and autistic features, which are sometimes the only evidence of disease for a year or more. Strabismus, nystagmus, and optic atrophy are common. Neuropsychiatric disturbances including impulsivity, poor attention span, hyperactivity, and emotional lability are also common. The course is fairly stable during early childhood and resembles static encephalopathy but is followed by neurologic deterioration between ages seven and 12 years. PLA2G6-related dystonia-parkinsonism has a variable age of onset, but most individuals present in early adulthood with gait disturbance or neuropsychiatric changes. Affected individuals consistently develop dystonia and parkinsonism (which may be accompanied by rapid cognitive decline) in their late teens to early twenties. Dystonia is most common in the hands and feet but may be more generalized. The most common features of parkinsonism in these individuals are bradykinesia, resting tremor, rigidity, and postural instability.</Attribute>
                    <XRef ID="NBK1675" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301718</ID>
                    <ID Source="BookShelf">NBK1675</ID>
                  </Citation>
                  <XRef ID="329303" DB="Orphanet" />
                  <XRef ID="CN204472" DB="MedGen" />
                  <XRef ID="MONDO:0017998" DB="MONDO" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="1718" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="5628" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A</ElementValue>
                    <XRef Type="MIM" ID="256600" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0001" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0007" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0003" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0014" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0015" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0004" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Infantile neuroaxonal dystrophy 1</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Seitelberger disease</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Infantile neuroaxonal dystrophy</ElementValue>
                    <XRef ID="Neuroaxonal+dystrophy%2C+infantile/5159" DB="Genetic Alliance" />
                    <XRef ID="52713000" DB="SNOMED CT" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">INAD1</ElementValue>
                    <XRef Type="MIM" ID="256600" DB="OMIM" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Preferred">NBIA2A</ElementValue>
                    <XRef Type="MIM" ID="256600" DB="OMIM" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Alternate">INAD</ElementValue>
                    <XRef Type="MIM" ID="256600" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="3957" />
                    <XRef ID="3957" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">PLA2G6-associated neurodegeneration (PLAN) comprises a continuum of three phenotypes with overlapping clinical and radiologic features: Infantile neuroaxonal dystrophy (INAD). Atypical neuroaxonal dystrophy (atypical NAD). PLA2G6-related dystonia-parkinsonism. INAD usually begins between ages six months and three years with psychomotor regression or delay, hypotonia, and progressive spastic tetraparesis. Many affected children never learn to walk or lose the ability shortly after attaining it. Strabismus, nystagmus, and optic atrophy are common. Disease progression is rapid, resulting in severe spasticity, progressive cognitive decline, and visual impairment. Many affected children do not survive beyond their first decade. Atypical NAD shows more phenotypic variability than INAD. In general, onset is in early childhood but can be as late as the end of the second decade. The presenting signs may be gait instability, ataxia, or speech delay and autistic features, which are sometimes the only evidence of disease for a year or more. Strabismus, nystagmus, and optic atrophy are common. Neuropsychiatric disturbances including impulsivity, poor attention span, hyperactivity, and emotional lability are also common. The course is fairly stable during early childhood and resembles static encephalopathy but is followed by neurologic deterioration between ages seven and 12 years. PLA2G6-related dystonia-parkinsonism has a variable age of onset, but most individuals present in early adulthood with gait disturbance or neuropsychiatric changes. Affected individuals consistently develop dystonia and parkinsonism (which may be accompanied by rapid cognitive decline) in their late teens to early twenties. Dystonia is most common in the hands and feet but may be more generalized. The most common features of parkinsonism in these individuals are bradykinesia, resting tremor, rigidity, and postural instability.</Attribute>
                    <XRef ID="NBK1675" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="keyword">PLA2G6-Associated Neurodegeneration</Attribute>
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301718</ID>
                    <ID Source="BookShelf">NBK1675</ID>
                  </Citation>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">23447832</ID>
                    <ID Source="BookShelf">NBK121988</ID>
                  </Citation>
                  <XRef ID="35069" DB="Orphanet" />
                  <XRef ID="C0270724" DB="MedGen" />
                  <XRef ID="MONDO:0024457" DB="MONDO" />
                  <XRef Type="MIM" ID="256600" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="20141" Type="Finding" ContributesToAggregateClassification="true">
                <Trait ID="30555" Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Iron accumulation in brain</ElementValue>
                    <XRef ID="HP:0012675" DB="Human Phenotype Ontology" />
                  </Name>
                  <XRef ID="C4021076" DB="MedGen" />
                  <XRef Type="primary" ID="HP:0012675" DB="Human Phenotype Ontology" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="424725" DB="ClinVar" />
          <XRef ID="CA173203" DB="ClinGen" />
          <XRef Type="rs" ID="587784329" DB="dbSNP" />
        </XRefList>
        <AlleleFrequencyList>
          <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
          <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
          <AlleleFrequency Value="0.00007" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        </AlleleFrequencyList>
      </SimpleAllele>
      <SimpleAllele AlleleID="198645" VariationID="242578">
        <GeneList>
          <Gene Symbol="PLA2G6" FullName="phospholipase A2 group VI" GeneID="8398" HGNC_ID="HGNC:9039" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>22q13.1</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="38111495" stop="38181830" display_start="38111495" display_stop="38181830" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="38507501" stop="38577835" display_start="38507501" display_stop="38577835" Strand="-" />
            </Location>
            <OMIM>603604</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_003560.4(PLA2G6):c.1942G&gt;A (p.Gly648Arg)</Name>
        <CanonicalSPDI>NC_000022.11:38115618:C:T</CanonicalSPDI>
        <VariantType>single nucleotide variant</VariantType>
        <Location>
          <CytogeneticLocation>22q13.1</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="38115619" stop="38115619" display_start="38115619" display_stop="38115619" variantLength="1" positionVCF="38115619" referenceAlleleVCF="C" alternateAlleleVCF="T" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="38511626" stop="38511626" display_start="38511626" display_stop="38511626" variantLength="1" positionVCF="38511626" referenceAlleleVCF="C" alternateAlleleVCF="T" />
        </Location>
        <ProteinChange>G648R</ProteinChange>
        <ProteinChange>G422R</ProteinChange>
        <ProteinChange>G470R</ProteinChange>
        <ProteinChange>G594R</ProteinChange>
        <ProteinChange>G416R</ProteinChange>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.38511626C&gt;T" Assembly="GRCh37">
              <Expression>NC_000022.10:g.38511626C&gt;T</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.38115619C&gt;T" Assembly="GRCh38">
              <Expression>NC_000022.11:g.38115619C&gt;T</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_007094.3" sequenceAccession="NG_007094" sequenceVersion="3" change="g.104160G&gt;A">
              <Expression>NG_007094.3:g.104160G&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_033059.2" sequenceAccession="NG_033059" sequenceVersion="2" change="g.51G&gt;A">
              <Expression>NG_033059.2:g.51G&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001004426.3" sequenceAccession="NM_001004426" sequenceVersion="3" change="c.1780G&gt;A">
              <Expression>NM_001004426.3:c.1780G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001004426.1" sequenceAccession="NP_001004426" sequenceVersion="1" change="p.Gly594Arg">
              <Expression>NP_001004426.1:p.Gly594Arg</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001199562.3" sequenceAccession="NM_001199562" sequenceVersion="3" change="c.1780G&gt;A">
              <Expression>NM_001199562.3:c.1780G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001186491.1" sequenceAccession="NP_001186491" sequenceVersion="1" change="p.Gly594Arg">
              <Expression>NP_001186491.1:p.Gly594Arg</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001349864.2" sequenceAccession="NM_001349864" sequenceVersion="2" change="c.1942G&gt;A">
              <Expression>NM_001349864.2:c.1942G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001336793.1" sequenceAccession="NP_001336793" sequenceVersion="1" change="p.Gly648Arg">
              <Expression>NP_001336793.1:p.Gly648Arg</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001349865.2" sequenceAccession="NM_001349865" sequenceVersion="2" change="c.1780G&gt;A">
              <Expression>NM_001349865.2:c.1780G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001336794.1" sequenceAccession="NP_001336794" sequenceVersion="1" change="p.Gly594Arg">
              <Expression>NP_001336794.1:p.Gly594Arg</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001349866.2" sequenceAccession="NM_001349866" sequenceVersion="2" change="c.1780G&gt;A">
              <Expression>NM_001349866.2:c.1780G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001336795.1" sequenceAccession="NP_001336795" sequenceVersion="1" change="p.Gly594Arg">
              <Expression>NP_001336795.1:p.Gly594Arg</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001349867.2" sequenceAccession="NM_001349867" sequenceVersion="2" change="c.1408G&gt;A">
              <Expression>NM_001349867.2:c.1408G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001336796.1" sequenceAccession="NP_001336796" sequenceVersion="1" change="p.Gly470Arg">
              <Expression>NP_001336796.1:p.Gly470Arg</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001349868.2" sequenceAccession="NM_001349868" sequenceVersion="2" change="c.1264G&gt;A">
              <Expression>NM_001349868.2:c.1264G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001336797.1" sequenceAccession="NP_001336797" sequenceVersion="1" change="p.Gly422Arg">
              <Expression>NP_001336797.1:p.Gly422Arg</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001349869.2" sequenceAccession="NM_001349869" sequenceVersion="2" change="c.1246G&gt;A">
              <Expression>NM_001349869.2:c.1246G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001336798.1" sequenceAccession="NP_001336798" sequenceVersion="1" change="p.Gly416Arg">
              <Expression>NP_001336798.1:p.Gly416Arg</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_003560.4" sequenceAccession="NM_003560" sequenceVersion="4" change="c.1942G&gt;A" MANESelect="true">
              <Expression>NM_003560.4:c.1942G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_003551.2" sequenceAccession="NP_003551" sequenceVersion="2" change="p.Gly648Arg">
              <Expression>NP_003551.2:p.Gly648Arg</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_1015" sequenceAccession="LRG_1015">
              <Expression>LRG_1015:g.104160G&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_1015t1" sequenceAccession="LRG_1015t1">
              <Expression>LRG_1015t1:c.1942G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_1015p1" sequenceAccession="LRG_1015p1" change="p.Gly648Arg">
              <Expression>LRG_1015p1:p.Gly648Arg</Expression>
            </ProteinExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2022-06-21" DateCreated="2020-01-07" MostRecentSubmission="2023-03-10" NumberOfSubmissions="2" NumberOfSubmitters="2">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Likely pathogenic</Description>
            <DescriptionHistory Dated="2020-01-08">
              <Description>no classification for the single variant</Description>
            </DescriptionHistory>
            <ConditionList>
              <TraitSet ID="1718" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="5628" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Infantile neuroaxonal dystrophy 1</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A</ElementValue>
                    <XRef Type="MIM" ID="256600" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0001" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0007" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0003" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0006" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0014" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0015" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="603604.0004" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Seitelberger disease</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Infantile neuroaxonal dystrophy</ElementValue>
                    <XRef ID="Neuroaxonal+dystrophy%2C+infantile/5159" DB="Genetic Alliance" />
                    <XRef ID="52713000" DB="SNOMED CT" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">INAD1</ElementValue>
                    <XRef Type="MIM" ID="256600" DB="OMIM" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Preferred">NBIA2A</ElementValue>
                    <XRef Type="MIM" ID="256600" DB="OMIM" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Alternate">INAD</ElementValue>
                    <XRef Type="MIM" ID="256600" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="keyword">PLA2G6-Associated Neurodegeneration</Attribute>
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">PLA2G6-associated neurodegeneration (PLAN) comprises a continuum of three phenotypes with overlapping clinical and radiologic features: Infantile neuroaxonal dystrophy (INAD). Atypical neuroaxonal dystrophy (atypical NAD). PLA2G6-related dystonia-parkinsonism. INAD usually begins between ages six months and three years with psychomotor regression or delay, hypotonia, and progressive spastic tetraparesis. Many affected children never learn to walk or lose the ability shortly after attaining it. Strabismus, nystagmus, and optic atrophy are common. Disease progression is rapid, resulting in severe spasticity, progressive cognitive decline, and visual impairment. Many affected children do not survive beyond their first decade. Atypical NAD shows more phenotypic variability than INAD. In general, onset is in early childhood but can be as late as the end of the second decade. The presenting signs may be gait instability, ataxia, or speech delay and autistic features, which are sometimes the only evidence of disease for a year or more. Strabismus, nystagmus, and optic atrophy are common. Neuropsychiatric disturbances including impulsivity, poor attention span, hyperactivity, and emotional lability are also common. The course is fairly stable during early childhood and resembles static encephalopathy but is followed by neurologic deterioration between ages seven and 12 years. PLA2G6-related dystonia-parkinsonism has a variable age of onset, but most individuals present in early adulthood with gait disturbance or neuropsychiatric changes. Affected individuals consistently develop dystonia and parkinsonism (which may be accompanied by rapid cognitive decline) in their late teens to early twenties. Dystonia is most common in the hands and feet but may be more generalized. The most common features of parkinsonism in these individuals are bradykinesia, resting tremor, rigidity, and postural instability.</Attribute>
                    <XRef ID="NBK1675" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="3957" />
                    <XRef ID="3957" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301718</ID>
                    <ID Source="BookShelf">NBK1675</ID>
                  </Citation>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">23447832</ID>
                    <ID Source="BookShelf">NBK121988</ID>
                  </Citation>
                  <XRef ID="35069" DB="Orphanet" />
                  <XRef ID="C0270724" DB="MedGen" />
                  <XRef ID="MONDO:0024457" DB="MONDO" />
                  <XRef Type="MIM" ID="256600" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef ID="CA358493" DB="ClinGen" />
          <XRef Type="rs" ID="794729212" DB="dbSNP" />
          <XRef Type="Interpreted" ID="424725" DB="ClinVar" />
        </XRefList>
      </SimpleAllele>
      <Name>NM_003560.3(PLA2G6):c.[1351delC];[1942G&gt;A]</Name>
      <VariationType>CompoundHeterozygote</VariationType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression>
            <Expression>NM_003560.3:c.[1351delC];[1942G&gt;A]</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </Genotype>
    <RCVList>
      <RCVAccession Title="NM_003560.3(PLA2G6):c.[1351delC];[1942G&gt;A] AND Infantile neuroaxonal dystrophy" Accession="RCV000184033" Version="3">
        <ClassifiedConditionList TraitSetID="1718">
          <ClassifiedCondition DB="MedGen" ID="C0270724">Infantile neuroaxonal dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-10-03" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2013-10-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-07-03" MostRecentSubmission="2015-07-03">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16783378</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301718</ID>
          <ID Source="BookShelf">NBK1675</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1718" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5628" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A</ElementValue>
                <XRef Type="MIM" ID="256600" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603604.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603604.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603604.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603604.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603604.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603604.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603604.0004" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Seitelberger disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Infantile neuroaxonal dystrophy</ElementValue>
                <XRef ID="Neuroaxonal+dystrophy%2C+infantile/5159" DB="Genetic Alliance" />
                <XRef ID="52713000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile neuroaxonal dystrophy 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">INAD1</ElementValue>
                <XRef Type="MIM" ID="256600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">NBIA2A</ElementValue>
                <XRef Type="MIM" ID="256600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">INAD</ElementValue>
                <XRef Type="MIM" ID="256600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">PLA2G6-Associated Neurodegeneration</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PLA2G6-associated neurodegeneration (PLAN) comprises a continuum of three phenotypes with overlapping clinical and radiologic features: Infantile neuroaxonal dystrophy (INAD). Atypical neuroaxonal dystrophy (atypical NAD). PLA2G6-related dystonia-parkinsonism. INAD usually begins between ages six months and three years with psychomotor regression or delay, hypotonia, and progressive spastic tetraparesis. Many affected children never learn to walk or lose the ability shortly after attaining it. Strabismus, nystagmus, and optic atrophy are common. Disease progression is rapid, resulting in severe spasticity, progressive cognitive decline, and visual impairment. Many affected children do not survive beyond their first decade. Atypical NAD shows more phenotypic variability than INAD. In general, onset is in early childhood but can be as late as the end of the second decade. The presenting signs may be gait instability, ataxia, or speech delay and autistic features, which are sometimes the only evidence of disease for a year or more. Strabismus, nystagmus, and optic atrophy are common. Neuropsychiatric disturbances including impulsivity, poor attention span, hyperactivity, and emotional lability are also common. The course is fairly stable during early childhood and resembles static encephalopathy but is followed by neurologic deterioration between ages seven and 12 years. PLA2G6-related dystonia-parkinsonism has a variable age of onset, but most individuals present in early adulthood with gait disturbance or neuropsychiatric changes. Affected individuals consistently develop dystonia and parkinsonism (which may be accompanied by rapid cognitive decline) in their late teens to early twenties. Dystonia is most common in the hands and feet but may be more generalized. The most common features of parkinsonism in these individuals are bradykinesia, resting tremor, rigidity, and postural instability.</Attribute>
                <XRef ID="NBK1675" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3957" />
                <XRef ID="3957" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301718</ID>
                <ID Source="BookShelf">NBK1675</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <XRef ID="35069" DB="Orphanet" />
              <XRef ID="C0270724" DB="MedGen" />
              <XRef ID="MONDO:0024457" DB="MONDO" />
              <XRef Type="MIM" ID="256600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="432883" SubmissionDate="2015-06-21" DateLastUpdated="2015-07-03" DateCreated="2015-07-03">
        <ClinVarSubmissionID localKey="NC_000022.10:g.[38511626C&gt;T];[38522454delG]|OMIM:256600" />
        <ClinVarAccession Accession="SCV000236564" DateUpdated="2015-07-03" DateCreated="2015-07-03" Type="SCV" Version="2" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-10-03">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16783378</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301718</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <Genotype>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="PLA2G6" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NC_000022.10:g.38511626C&gt;T</Attribute>
            </AttributeSet>
            <AttributeSet>
              <Attribute Type="HGVS">NC_000022.10:g.38511626C&gt;T</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="PLA2G6" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NC_000022.10:g.38522454delG</Attribute>
            </AttributeSet>
            <AttributeSet>
              <Attribute Type="HGVS">NC_000022.10:g.38522454delG</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <VariationType>CompoundHeterozygote</VariationType>
        </Genotype>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Infantile neuroaxonal dystrophy</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="256600" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_005</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="432883" TraitType="Disease" MappingType="Name" MappingValue="Infantile neuroaxonal dystrophy" MappingRef="Preferred">
        <MedGen CUI="C0270724" Name="Infantile neuroaxonal dystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

